Literature DB >> 15111472

Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials.

Eric Wooltorton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111472      PMCID: PMC395813          DOI: 10.1503/cmaj.1040539

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Choice of an antipsychotic.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2003-12-22       Impact factor: 1.909

2.  Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

  2 in total
  47 in total

Review 1.  Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.

Authors:  Salvatore Gentile
Journal:  Psychopharmacology (Berl)       Date:  2010-07-27       Impact factor: 4.530

Review 2.  Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

Authors:  Nathan Herrmann; Krista L Lanctôt
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Increased mortality among elderly patients with dementia using atypical antipsychotics.

Authors:  Sonal Singh; Eric Wooltorton
Journal:  CMAJ       Date:  2005-07-13       Impact factor: 8.262

Review 4.  Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review.

Authors:  Louis S Matza; Timothy M Baker; Dennis A Revicki
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Controversies in behavioral neurology: the use of atypical antipsychotic drugs to treat neurobehavioral symptoms in dementia.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

Review 6.  Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.

Authors:  Gianluca Trifiró; Janet Sultana; Edoardo Spina
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

Review 7.  Alternatives to atypical antipsychotics for the management of dementia-related agitation.

Authors:  Michael J Passmore; David M Gardner; Yvette Polak; Kiran Rabheru
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review.

Authors:  Emilio Sacchetti; Cesare Turrina; Paolo Valsecchi
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

Review 9.  The link between psychosis and aggression in persons with dementia: a systematic review.

Authors:  Denis Shub; Valdesha Ball; Asghar-Ali Ali Abbas; Aruna Gottumukkala; Mark E Kunik
Journal:  Psychiatr Q       Date:  2010-06

10.  Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole.

Authors:  Izchak Kohen; Paula E Lester; Sum Lam
Journal:  Neuropsychiatr Dis Treat       Date:  2010-03-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.